FDA panel votes unanimously in favor of Merck & Co's Sugammadex
November 06, 2015 at 14:03 PM EST
Nov 6 (Reuters) - Merck & Co's drug to reverse the effects of muscle relaxants used in surgery is safe and effective enough to warrant approval, an independent panel to the U.S. Food and Drug Administration said on Friday.
